We are working closely with Rice University to monitor the continued impact of Covid-19 on our community. The health and safety of our guests and staff are our top priority. All gatherings at Baker Hall through April 30 have been canceled. A current list of scheduled online events is available at bakerinstitute.org/events and will be updated with new webcasts and webinars. Please refer to emergency.rice.edu/coronavirus for additional information and updates.
My research focuses on how regulations and policies affect stem cell research locally, nationally and internationally. In addition, I am tracking current events such as court cases and media coverage that impact stem cell policy and the ability to conduct stem cell research. I also investigate the ethical and moral issues that arise with the advancement of new biomedical technologies.
Maude Rowland Cuchiara, Ph.D., is a nonresident scholar for the Science and Technology Policy Program. Cuchiara actively works with the International Stem Cell Policy Program to research and write science policy reports and peer-reviewed publications. She is specifically interested in issues involving the patenting of cell-based therapies and the use of stem cell interventions outside of peer-reviewed clinical trials. Such “unproven stem cell treatments” can lead patients with debilitating diseases and limited options to seek expensive interventions that lack reliable scientific data. Cuchiara’s other research interests include science and math education, biomedical research, and science diplomacy.
Cuchiara received a B.A. in Spanish and a B.S. in biomedical engineering from North Carolina State University and a Ph.D. in bioengineering from Rice University. She is currently a research scientist and lab manager at Duke University with Jennifer West, Ph.D.